NewsNew nanocarrier drug delivery technology crosses the
blood-brain barrier

17th April 2020by admin0
https://nfusion-tech.com/wp-content/uploads/2020/04/new-nanocarrier-drug-delivery-technology-crosses-theblood-brain-barrier_5e9ab7d0b59a3.jpeg

A Japanese research team has developed a cyclic
peptide (a chain of amino acids bonded circularly) that enhances
blood-brain barrier (BBB) penetration. By attaching the cyclic
peptide to the surface of nanoparticles, research and development
of new drug nanocarriers for drug delivery to the brain becomes
possible.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2020 New Fusion All Rights Reserved

      Designed by FallingBrick


      Warning: Creating default object from empty value in /homepages/9/d775151175/htdocs/nfusion-tech.com/wp-content/plugins/applauz/framework_bt_plugin/.framework_bt_plugin.php on line 1640